SCHEMBL7067053

SCHEMBL7067053

C[C@H](CC(CC(N)=O)C(=O)N(O)[C@@H](Cc1ccccc1)C(=S)NCCCc1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.42
EPHX2 P34913 6/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KMT2A Q03164 2/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KDM4A O75164 1/20 0.39
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
CNR2 P34972 2/20 0.38
POLB P06746 1/20 0.37
MMP8 P22894 1/20 0.37
KCNA5 P22460 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7067062 0.92 MMP8 (0.43) CNR1EPHX2NPC1RAB9ASMN1; SMN2
SCHEMBL7069865 0.87 CNR1 (0.41) CNR1EPHX2NPC1RAB9AKMT2A
SCHEMBL7066782 0.87 MMP2 (0.46) CNR1EPHX2KMT2A
SCHEMBL7070491 0.78 MMP2 (0.42) MMP8
SCHEMBL7068112 0.74 EPHX2 (0.47) CNR1EPHX2NPC1RAB9ASMN1; SMN2
SCHEMBL7068109 0.74 EPHX2 (0.47) CNR1EPHX2NPC1RAB9ASMN1; SMN2
SCHEMBL7067048 0.67 EPHX2 (0.43) CNR1EPHX2NPC1RAB9ASMN1; SMN2
SCHEMBL7072801 0.67 MMP2 (0.56) MMP8
SCHEMBL8399907 0.65 MMP2 (0.55)
SCHEMBL7982892 0.64 ACE (0.52) KMT2ACYP2D6CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1060161-B1 MATRIX METALLOPROTEINASE INHIBITORS LEO PHARMA AS WITH SECONDARY N (DK) 2003-06-11 EP claimed
US-6277876-B1 Matrix metalloproteinase inhibitors LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2001-08-21 US claimed
EP-1060161-B1 MATRIX METALLOPROTEINASE INHIBITORS LEO PHARMA AS WITH SECONDARY N (DK) 2003-06-11 EP disclosed